Vitale Antonio

8PUBLICATIONS
29CO-AUTHORS
Molecular targetsTumour immunologyPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Feb 27, 2026
PIK3CA Alterations in NSCLC: Clinical Characteristics of a "Neglected" Population of Oncogene-Addicted Patients.

Sabrina Rossi, Arianna Pagliaro, Silvia Masini

|Aug 08, 2025
Unlocking the Immune Response in ALK-Rearranged Lung Adenocarcinoma.

Antonio Vitale, Emilio Bria

|Apr 23, 2025
COVALENCE STUDY: Immunogenicity and Reactogenicity of a COVID-19 mRNA Vaccine in an Open-Label Cohort of Long-Survivor Patients with Metastatic Lung Cancer.

Emanuele Vita, Federico Monaca, Luca Mastrantoni

|Mar 20, 2025
Overcoming amplification-mediated resistance to sotorasib by dose re-escalation in KRAS G12C mutant NSCLC: a case report.

Antonio Vitale, Emanuele Vita, Alessio Stefani

|Oct 07, 2024
Impact of Comprehensive Genome Profiling on the Management of Advanced Non-Small Cell Lung Cancer: Preliminary Results From the Lung Cancer Cohort of the FPG500 Program.

Antonio Vitale, Luca Mastrantoni, Jacopo Russo

|Mar 29, 2024
Symptomatic androgen deficiency and sexual dysfunctions in male patients receiving alectinib for ALK-positive advanced non-small cell lung cancer.

Emanuele Vita, Federico Monaca, Domenico Milardi

Pageof 2

Frequent Collaborators

5 joint publications

Emilio Bria

3 joint publications

Emanuele Vita

2 joint publications

Sabrina Rossi

2 joint publications

Luca Mastrantoni